|
G |
Ache |
acetylcholinesterase |
multiple interactions |
ISO EXP |
protocatechuic acid inhibits the reaction [sodium arsenite results in decreased activity of ACHE protein] protocatechuic acid inhibits the reaction [Cadmium Chloride results in increased activity of ACHE protein] |
CTD |
PMID:32392679 PMID:33497687 |
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Akr1b1 |
aldo-keto reductase family 1 member B1 |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [Galactose results in increased expression of AKR1B1 mRNA] |
CTD |
PMID:22687555 |
|
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
|
|
G |
App |
amyloid beta precursor protein |
multiple interactions |
ISO |
Gallic Acid inhibits the reaction [protocatechuic acid inhibits the reaction [APP protein modified form binds to APP protein modified form]]; protocatechuic acid inhibits the reaction [APP protein modified form binds to APP protein modified form] |
CTD |
PMID:22129351 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions |
ISO EXP |
protocatechuic acid inhibits the reaction [sodium arsenite results in increased expression of BAX mRNA]; protocatechuic acid inhibits the reaction [sodium arsenite results in increased expression of BAX protein] protocatechuic acid inhibits the reaction [Cadmium Chloride results in increased expression of BAX mRNA]; protocatechuic acid inhibits the reaction [Isoproterenol results in increased expression of BAX protein] |
CTD |
PMID:32392679 PMID:33497687 PMID:36593721 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions |
EXP ISO |
protocatechuic acid inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 mRNA]; protocatechuic acid inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]; protocatechuic acid inhibits the reaction [Isoproterenol results in decreased expression of BCL2 protein]; protocatechuic acid inhibits the reaction [Rotenone results in decreased expression of BCL2 protein] protocatechuic acid inhibits the reaction [sodium arsenite results in decreased expression of BCL2 mRNA]; protocatechuic acid inhibits the reaction [sodium arsenite results in decreased expression of BCL2 protein] |
CTD |
PMID:18082360 PMID:32392679 PMID:33497687 PMID:36593721 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
multiple interactions |
ISO EXP |
protocatechuic acid inhibits the reaction [sodium arsenite results in decreased expression of BDNF protein] protocatechuic acid inhibits the reaction [Cadmium Chloride results in decreased expression of BDNF protein] |
CTD |
PMID:32392679 PMID:33497687 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
EXP ISO |
protocatechuic acid inhibits the reaction [Cadmium Chloride results in increased activity of CASP3 protein]; protocatechuic acid inhibits the reaction [Cadmium Chloride results in increased expression of CASP3 mRNA]; protocatechuic acid inhibits the reaction [furan results in increased activity of CASP3 protein]; protocatechuic acid inhibits the reaction [Isoproterenol results in increased activity of CASP3 protein]; protocatechuic acid inhibits the reaction [Rotenone results in increased activity of CASP3 protein] protocatechuic acid inhibits the reaction [sodium arsenite results in increased activity of CASP3 protein]; protocatechuic acid inhibits the reaction [sodium arsenite results in increased expression of CASP3 mRNA] |
CTD |
PMID:18082360 PMID:32392679 PMID:32758512 PMID:33497687 PMID:36593721 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
EXP |
protocatechuic acid inhibits the reaction [furan results in increased activity of CASP9 protein] |
CTD |
PMID:32758512 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
increases activity multiple interactions |
EXP ISO |
protocatechuic acid results in increased activity of CAT protein protocatechuic acid inhibits the reaction [Lipopolysaccharides results in decreased expression of CAT protein]; protocatechuic acid inhibits the reaction [sodium arsenite results in decreased activity of CAT protein]; protocatechuic acid inhibits the reaction [sodium arsenite results in decreased expression of CAT mRNA] protocatechuic acid inhibits the reaction [Cadmium Chloride results in decreased activity of CAT protein]; protocatechuic acid inhibits the reaction [Cadmium Chloride results in decreased expression of CAT mRNA]; protocatechuic acid inhibits the reaction [furan results in decreased activity of CAT protein]; protocatechuic acid inhibits the reaction [Isoproterenol results in decreased activity of CAT protein] |
CTD |
PMID:29842870 PMID:32392679 PMID:32758512 PMID:33497687 PMID:36593721 PMID:36807594 More...
|
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein] |
CTD |
PMID:31306686 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression |
EXP |
protocatechuic acid results in increased expression of CDKN1A protein |
CTD |
PMID:16227210 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Comt |
catechol-O-methyltransferase |
increases methylation |
ISO EXP |
COMT protein results in increased methylation of protocatechuic acid |
CTD |
PMID:11160877 |
|
NCBI chr11:82,568,052...82,587,642
Ensembl chr11:82,568,025...82,587,642
|
|
G |
Cs |
citrate synthase |
increases activity |
ISO |
protocatechuic acid results in increased activity of CS protein |
CTD |
PMID:31306686 |
|
NCBI chr 7:758,074...791,421
Ensembl chr 7:758,345...791,421
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions |
EXP |
protocatechuic acid inhibits the reaction [Methylcholanthrene results in increased activity of CYP1A1 protein] |
CTD |
PMID:15302093 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions |
EXP |
protocatechuic acid inhibits the reaction [Methylcholanthrene results in increased activity of CYP1A2 protein] |
CTD |
PMID:15302093 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions decreases activity |
EXP |
[protocatechuic acid co-treated with Methylcholanthrene] results in decreased activity of CYP2E1 protein protocatechuic acid results in decreased activity of CYP2E1 protein |
CTD |
PMID:15302093 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Eno1 |
enolase 1 |
increases expression |
ISO |
protocatechuic acid results in increased expression of ENO1 mRNA |
CTD |
PMID:16227210 |
|
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336 Ensembl chr 3:160,719,951...160,731,336
|
|
G |
Epo |
erythropoietin |
increases expression multiple interactions |
EXP |
protocatechuic acid results in increased expression of EPO protein protocatechuic acid inhibits the reaction [methylmercuric chloride results in decreased expression of EPO protein]; protocatechuic acid inhibits the reaction [Methylmercury Compounds results in decreased expression of EPO protein] |
CTD |
PMID:31850806 PMID:32461003 |
|
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
increases expression multiple interactions |
EXP |
protocatechuic acid results in increased expression of FSHB protein protocatechuic acid inhibits the reaction [furan results in decreased expression of FSHB protein] |
CTD |
PMID:29842870 PMID:32758512 |
|
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
increases activity multiple interactions |
EXP |
protocatechuic acid results in increased activity of G6PD protein protocatechuic acid inhibits the reaction [furan results in decreased activity of G6PD protein] |
CTD |
PMID:29842870 PMID:32758512 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Glo1 |
glyoxalase 1 |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [Galactose results in decreased expression of and results in decreased activity of GLO1 protein] |
CTD |
PMID:22687555 |
|
NCBI chr20:8,663,617...8,681,661
Ensembl chr20:8,662,801...8,681,649
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
increases expression multiple interactions |
ISO EXP |
protocatechuic acid results in increased expression of GPX1 mRNA protocatechuic acid inhibits the reaction [sodium arsenite results in decreased expression of GPX1 mRNA] protocatechuic acid inhibits the reaction [Cadmium Chloride results in decreased expression of GPX1 mRNA] |
CTD |
PMID:32392679 PMID:33497687 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions increases activity increases expression |
ISO EXP |
protocatechuic acid inhibits the reaction [sodium arsenite results in decreased activity of GSR protein]; protocatechuic acid inhibits the reaction [sodium arsenite results in decreased expression of GSR mRNA] protocatechuic acid results in increased activity of GSR protein protocatechuic acid results in increased expression of GSR mRNA protocatechuic acid inhibits the reaction [Cadmium Chloride results in decreased expression of GSR mRNA]; protocatechuic acid inhibits the reaction [Isoproterenol results in decreased activity of GSR protein] |
CTD |
PMID:32392679 PMID:33497687 PMID:36593721 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
increases stability multiple interactions increases expression |
EXP |
protocatechuic acid results in increased stability of HIF1A protein protocatechuic acid inhibits the reaction [methylmercuric chloride results in decreased expression of HIF1A protein]; protocatechuic acid inhibits the reaction [Methylmercury Compounds results in decreased expression of HIF1A protein] protocatechuic acid results in increased expression of HIF1A protein |
CTD |
PMID:16227210 PMID:31850806 PMID:32461003 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions increases expression |
EXP |
protocatechuic acid inhibits the reaction [Isoproterenol results in decreased expression of HMOX1 mRNA] protocatechuic acid results in increased expression of HMOX1 mRNA |
CTD |
PMID:36593721 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [Lipopolysaccharides results in increased expression of IKBKB protein] |
CTD |
PMID:36807594 |
|
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
EXP |
protocatechuic acid inhibits the reaction [furan results in decreased expression of IL10 protein] |
CTD |
PMID:32758512 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO EXP |
protocatechuic acid inhibits the reaction [Galactose results in increased secretion of IL1B protein]; protocatechuic acid inhibits the reaction [sodium arsenite results in increased expression of IL1B mRNA]; protocatechuic acid inhibits the reaction [sodium arsenite results in increased expression of IL1B protein] protocatechuic acid inhibits the reaction [Cadmium Chloride results in increased expression of IL1B mRNA]; protocatechuic acid inhibits the reaction [Cadmium Chloride results in increased expression of IL1B protein]; protocatechuic acid inhibits the reaction [furan results in increased expression of IL1B protein]; protocatechuic acid inhibits the reaction [Isoproterenol results in increased expression of IL1B protein] |
CTD |
PMID:22687555 PMID:32392679 PMID:32758512 PMID:33497687 PMID:36593721 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [Galactose results in increased secretion of IL6 protein] |
CTD |
PMID:22687555 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ldhc |
lactate dehydrogenase C |
increases activity |
EXP |
protocatechuic acid results in increased activity of LDHC protein |
CTD |
PMID:29842870 |
|
NCBI chr 1:97,385,984...97,403,382
Ensembl chr 1:97,382,379...97,403,378
|
|
G |
Lhb |
luteinizing hormone subunit beta |
increases expression multiple interactions |
EXP |
protocatechuic acid results in increased expression of LHB protein protocatechuic acid inhibits the reaction [furan results in decreased expression of LHB protein] |
CTD |
PMID:29842870 PMID:32758512 |
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [Lipopolysaccharides results in increased expression of MAPK1 protein] |
CTD |
PMID:36807594 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [Lipopolysaccharides results in increased expression of MAPK3 protein] |
CTD |
PMID:36807594 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mpo |
myeloperoxidase |
increases activity decreases activity multiple interactions |
ISO EXP |
protocatechuic acid results in increased activity of MPO protein protocatechuic acid results in decreased activity of MPO protein protocatechuic acid inhibits the reaction [furan results in increased activity of MPO protein] |
CTD |
PMID:24060682 PMID:29842870 PMID:32758512 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions increases expression |
EXP ISO |
[protocatechuic acid co-treated with Cadmium Chloride] results in increased expression of NFE2L2 mRNA; protocatechuic acid inhibits the reaction [Isoproterenol results in decreased expression of NFE2L2 mRNA] protocatechuic acid results in increased expression of NFE2L2 mRNA protocatechuic acid inhibits the reaction [Lipopolysaccharides results in decreased expression of NFE2L2 mRNA] |
CTD |
PMID:32392679 PMID:36593721 PMID:36807594 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkbib |
NFKB inhibitor beta |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of NFKBIB protein] |
CTD |
PMID:20026373 |
|
NCBI chr 1:84,046,292...84,053,862
Ensembl chr 1:84,046,295...84,053,862
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO EXP |
protocatechuic acid inhibits the reaction [[Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein] which results in increased abundance of Nitrites]; protocatechuic acid inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; protocatechuic acid inhibits the reaction [sodium arsenite results in increased expression of NOS2 mRNA]; protocatechuic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NOS2 protein] protocatechuic acid inhibits the reaction [Cadmium Chloride results in increased expression of NOS2 mRNA] |
CTD |
PMID:20026373 PMID:31306686 PMID:32392679 PMID:33497687 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions increases activity |
EXP ISO |
[protocatechuic acid co-treated with Methylcholanthrene] results in increased activity of NQO1 protein protocatechuic acid results in increased activity of NQO1 protein protocatechuic acid inhibits the reaction [Lipopolysaccharides results in decreased expression of NQO1 mRNA] |
CTD |
PMID:15302093 PMID:36807594 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Prl |
prolactin |
multiple interactions |
EXP |
protocatechuic acid inhibits the reaction [furan results in decreased expression of PRL protein] |
CTD |
PMID:32758512 |
|
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [Galactose results in increased expression of PTGS2 mRNA]; protocatechuic acid inhibits the reaction [Galactose results in increased expression of PTGS2 protein]; protocatechuic acid inhibits the reaction [Lipopolysaccharides results in decreased expression of PTGS2 protein]; protocatechuic acid inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]; protocatechuic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of and results in increased expression of PTGS2 protein] |
CTD |
PMID:20026373 PMID:22687555 PMID:31306686 PMID:36807594 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO EXP |
protocatechuic acid inhibits the reaction [Galactose results in increased expression of and results in increased activity of RELA protein]; protocatechuic acid inhibits the reaction [Galactose results in increased expression of RELA mRNA]; protocatechuic acid inhibits the reaction [Galactose results in increased expression of RELA protein]; protocatechuic acid inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of RELA protein] protocatechuic acid inhibits the reaction [Isoproterenol results in increased expression of RELA protein] |
CTD |
PMID:20026373 PMID:22687555 PMID:36593721 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Sele |
selectin E |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [TNF protein results in increased expression of SELE protein] |
CTD |
PMID:30611791 |
|
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
increases expression multiple interactions |
EXP |
protocatechuic acid results in increased expression of SLC2A1 protein protocatechuic acid inhibits the reaction [methylmercuric chloride results in decreased expression of SLC2A1 protein]; protocatechuic acid inhibits the reaction [Methylmercury Compounds results in decreased expression of SLC2A1 protein] |
CTD |
PMID:31850806 PMID:32461003 |
|
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions increases expression |
ISO EXP |
protocatechuic acid inhibits the reaction [sodium arsenite results in decreased expression of SOD2 mRNA] protocatechuic acid results in increased expression of SOD2 mRNA protocatechuic acid inhibits the reaction [Cadmium Chloride results in decreased expression of SOD2 mRNA] |
CTD |
PMID:32392679 PMID:33497687 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
EXP |
protocatechuic acid inhibits the reaction [Isoproterenol results in increased expression of TGFB1 protein] |
CTD |
PMID:36593721 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tlr4 |
toll-like receptor 4 |
multiple interactions |
ISO |
protocatechuic acid inhibits the reaction [Lipopolysaccharides results in increased expression of TLR4 protein] |
CTD |
PMID:36807594 |
|
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO EXP |
protocatechuic acid inhibits the reaction [Galactose results in increased secretion of TNF protein]; protocatechuic acid inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]; protocatechuic acid inhibits the reaction [sodium arsenite results in increased expression of TNF mRNA]; protocatechuic acid inhibits the reaction [sodium arsenite results in increased expression of TNF protein] protocatechuic acid inhibits the reaction [TNF protein results in increased expression of SELE protein] protocatechuic acid inhibits the reaction [Cadmium Chloride results in increased expression of TNF mRNA]; protocatechuic acid inhibits the reaction [Cadmium Chloride results in increased expression of TNF protein]; protocatechuic acid inhibits the reaction [furan results in increased expression of TNF protein]; protocatechuic acid inhibits the reaction [Isoproterenol results in increased expression of TNF protein] |
CTD |
PMID:22687555 PMID:30611791 PMID:31306686 PMID:32392679 PMID:32758512 PMID:33497687 PMID:36593721 More...
|
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Vegfa |
vascular endothelial growth factor A |
increases expression multiple interactions |
EXP |
protocatechuic acid results in increased expression of VEGFA protein protocatechuic acid inhibits the reaction [methylmercuric chloride results in decreased expression of VEGFA protein]; protocatechuic acid inhibits the reaction [Methylmercury Compounds results in decreased expression of VEGFA protein] |
CTD |
PMID:16227210 PMID:31850806 PMID:32461003 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
multiple interactions |
ISO |
ethyl protocatechuate inhibits the reaction [rosiglitazone results in increased expression of FABP4 mRNA] |
CTD |
PMID:24338020 |
|
NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:91,580,885...91,585,578
|
|
G |
Gata3 |
GATA binding protein 3 |
multiple interactions |
ISO |
ethyl protocatechuate inhibits the reaction [rosiglitazone results in increased ubiquitination of and results in increased degradation of GATA3 protein] |
CTD |
PMID:24338020 |
|
NCBI chr17:68,643,760...68,666,000
Ensembl chr17:68,643,873...68,665,391
|
|
G |
Klf2 |
KLF transcription factor 2 |
multiple interactions |
ISO |
ethyl protocatechuate inhibits the reaction [rosiglitazone results in increased ubiquitination of and results in increased degradation of KLF2 protein] |
CTD |
PMID:24338020 |
|
NCBI chr16:17,521,107...17,523,739
Ensembl chr16:17,514,552...17,523,944
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions |
ISO |
ethyl protocatechuate inhibits the reaction [rosiglitazone results in increased expression of PPARG mRNA] |
CTD |
PMID:24338020 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Sp7 |
Sp7 transcription factor |
multiple interactions |
ISO |
ethyl protocatechuate inhibits the reaction [Ascorbic Acid results in increased expression of SP7 mRNA]; ethyl protocatechuate inhibits the reaction [Ascorbic Acid results in increased expression of SP7 protein] |
CTD |
PMID:21467157 |
|
NCBI chr 7:133,484,609...133,494,788
Ensembl chr 7:133,484,609...133,494,847
|
|
G |
Tafazzin |
tafazzin, phospholipid-lysophospholipid transacylase |
multiple interactions |
ISO |
ethyl protocatechuate inhibits the reaction [Rosiglitazone results in increased ubiquitination of and results in increased degradation of TAFAZZIN protein] |
CTD |
PMID:24338020 |
|
NCBI chr X:152,065,539...152,076,178
Ensembl chr X:152,065,609...152,074,001
|
|